Eric Warren
Chief Commercial Officer, Esperion Therapeutics.
Companies
- Mineralys Therapeutics, Inc.Chief Commercial Officer Mar 4, 2026 to now1
- Esperion TherapeuticsChief Commercial Officer Mar 9, 2022 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mineralys Therapeutics, Inc. MLYS38,400 shares3$803.7K at $20.93Sep 21, 2026
- Esperion Therapeutics ESPR370,218 shares4Apr 17, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 21, 2026Sold 7,438 shares at $28.12 of Mineralys Therapeutics, Inc.3
- Sep 21, 2026Exercised options 7,438 shares at $13.24 of Mineralys Therapeutics, Inc.3
- Aug 21, 2026Sold 7,437 shares at $25.98 of Mineralys Therapeutics, Inc.5
- Aug 21, 2026Exercised options 7,437 shares at $13.24 of Mineralys Therapeutics, Inc.5
- Jul 21, 2026Sold 7,438 shares at $26.87 of Mineralys Therapeutics, Inc.6
- Jul 21, 2026Exercised options 7,438 shares at $13.24 of Mineralys Therapeutics, Inc.6
- Jun 26, 2026Sold 104,124 shares at $25.90 of Mineralys Therapeutics, Inc.7
- Jun 26, 2026Exercised options 104,124 shares at $13.24 of Mineralys Therapeutics, Inc.7
- Apr 17, 2025Sold 108 shares at $0.98 of Esperion Therapeutics4
- Mar 18, 2025Sold 2,433 shares at $1.49 of Esperion Therapeutics8
- Mar 14, 2025Granted 213,000 shares of Esperion Therapeutics9
- Feb 19, 2025Sold 239 shares at $1.87 of Esperion Therapeutics10
- Jan 17, 2025Sold 123 shares at $2.26 of Esperion Therapeutics11
- Dec 17, 2024Sold 2,234 shares at $2.43 of Esperion Therapeutics12
- Nov 19, 2024Sold 197 shares at $2.17 of Esperion Therapeutics13
- Oct 17, 2024Sold 107 shares at $2.12 of Esperion Therapeutics14
- Sep 17, 2024Sold 2,608 shares at $1.78 of Esperion Therapeutics15
- Aug 19, 2024Sold 211 shares at $1.95 of Esperion Therapeutics16
- Jul 17, 2024Sold 108 shares at $2.59 of Esperion Therapeutics17
- Jun 18, 2024Sold 2,540 shares at $2.86 of Esperion Therapeutics18
- May 17, 2024Sold 192 shares at $2.48 of Esperion Therapeutics19
- Mar 14, 2024Granted 100,000 shares of Esperion Therapeutics20
- Sep 20, 2023Sold 742 shares at $1.25 of Esperion Therapeutics21
- Aug 18, 2023Sold 243 shares at $1.41 of Esperion Therapeutics22
- Jul 19, 2023Sold 106 shares at $1.59 of Esperion Therapeutics23
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Aug 25, 2026
- 6SEC EDGARForm 4 filed Jul 23, 2026
- 7SEC EDGARForm 4 filed Jun 30, 2026
- 8SEC EDGARForm 4 filed Mar 19, 2025
- 9SEC EDGARForm 4 filed Mar 17, 2025
- 10SEC EDGARForm 4 filed Feb 20, 2025
- 11SEC EDGARForm 4 filed Jan 21, 2025
- 12SEC EDGARForm 4 filed Dec 18, 2024
- 13SEC EDGARForm 4 filed Nov 20, 2024
- 14SEC EDGARForm 4 filed Oct 18, 2024
- 15SEC EDGARForm 4 filed Sep 18, 2024
- 16SEC EDGARForm 4 filed Aug 20, 2024
- 17SEC EDGARForm 4 filed Jul 19, 2024
- 18SEC EDGARForm 4 filed Jun 20, 2024
- 19SEC EDGARForm 4 filed May 20, 2024
- 20SEC EDGARForm 4 filed Mar 15, 2024
- 21SEC EDGARForm 4 filed Sep 21, 2023
- 22SEC EDGARForm 4 filed Aug 21, 2023
- 23SEC EDGARForm 4 filed Jul 20, 2023